

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 5.09584127 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.60817250 |
| 3 | negative regulation of protein localization to cell surface (GO:2000009) | 4.31547664 |
| 4 | thrombin receptor signaling pathway (GO:0070493) | 4.06370720 |
| 5 | regulation of platelet aggregation (GO:0090330) | 3.99930756 |
| 6 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.82931714 |
| 7 | actin-myosin filament sliding (GO:0033275) | 3.79453092 |
| 8 | muscle filament sliding (GO:0030049) | 3.79453092 |
| 9 | adenosine receptor signaling pathway (GO:0001973) | 3.77236890 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.69632677 |
| 11 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.56361862 |
| 12 | relaxation of muscle (GO:0090075) | 3.49114916 |
| 13 | regulation of lipoprotein metabolic process (GO:0050746) | 3.48084976 |
| 14 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.42328366 |
| 15 | regulation of platelet activation (GO:0010543) | 3.37425000 |
| 16 | relaxation of cardiac muscle (GO:0055119) | 3.37347101 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.28020292 |
| 18 | negative regulation of heart contraction (GO:0045822) | 3.25943113 |
| 19 | platelet aggregation (GO:0070527) | 3.25455005 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25277794 |
| 21 | actin-mediated cell contraction (GO:0070252) | 3.21574646 |
| 22 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.20470619 |
| 23 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.17224183 |
| 24 | skeletal muscle contraction (GO:0003009) | 3.16550963 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.16148476 |
| 26 | negative regulation of norepinephrine secretion (GO:0010700) | 3.12589659 |
| 27 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.07541133 |
| 28 | negative regulation of heart rate (GO:0010459) | 3.07088755 |
| 29 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.06975788 |
| 30 | detection of light stimulus involved in visual perception (GO:0050908) | 3.06975788 |
| 31 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.06549931 |
| 32 | negative regulation of muscle contraction (GO:0045932) | 3.05808690 |
| 33 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04827762 |
| 34 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.94787095 |
| 35 | neuronal action potential propagation (GO:0019227) | 2.94768318 |
| 36 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.94626314 |
| 37 | angiogenesis involved in wound healing (GO:0060055) | 2.93490863 |
| 38 | negative regulation of platelet activation (GO:0010544) | 2.91869935 |
| 39 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.87454043 |
| 40 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.86801805 |
| 41 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.86801805 |
| 42 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.86576597 |
| 43 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.84135356 |
| 44 | protein localization to microtubule (GO:0035372) | 2.81628362 |
| 45 | response to inactivity (GO:0014854) | 2.79181098 |
| 46 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.79020764 |
| 47 | regulation of protein localization to cell surface (GO:2000008) | 2.78327705 |
| 48 | positive regulation of muscle hypertrophy (GO:0014742) | 2.78296090 |
| 49 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.78296090 |
| 50 | autophagic vacuole fusion (GO:0000046) | 2.78056198 |
| 51 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.77008832 |
| 52 | regulation of relaxation of muscle (GO:1901077) | 2.76560943 |
| 53 | blood coagulation, intrinsic pathway (GO:0007597) | 2.76184386 |
| 54 | regulation of synapse structural plasticity (GO:0051823) | 2.73026246 |
| 55 | positive regulation of bone resorption (GO:0045780) | 2.72455672 |
| 56 | positive regulation of bone remodeling (GO:0046852) | 2.72455672 |
| 57 | fatty acid elongation (GO:0030497) | 2.71306903 |
| 58 | myotube differentiation (GO:0014902) | 2.71088028 |
| 59 | positive regulation of receptor recycling (GO:0001921) | 2.69694739 |
| 60 | protein neddylation (GO:0045116) | 2.69103285 |
| 61 | regulation of cell communication by electrical coupling (GO:0010649) | 2.68992357 |
| 62 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.68821729 |
| 63 | negative regulation of blood circulation (GO:1903523) | 2.68470973 |
| 64 | relaxation of smooth muscle (GO:0044557) | 2.66323711 |
| 65 | platelet degranulation (GO:0002576) | 2.64308906 |
| 66 | synaptic vesicle exocytosis (GO:0016079) | 2.63984888 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.63965003 |
| 68 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.61869599 |
| 69 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.60003412 |
| 70 | positive regulation of microtubule polymerization (GO:0031116) | 2.59615043 |
| 71 | regulation of female receptivity (GO:0045924) | 2.59356937 |
| 72 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.58872346 |
| 73 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.57618282 |
| 74 | actin filament-based movement (GO:0030048) | 2.57011747 |
| 75 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.56404658 |
| 76 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.56404658 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 2.56028244 |
| 78 | nerve growth factor signaling pathway (GO:0038180) | 2.55954856 |
| 79 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.54829199 |
| 80 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.54629108 |
| 81 | regulation of receptor recycling (GO:0001919) | 2.53951039 |
| 82 | negative regulation of inclusion body assembly (GO:0090084) | 2.53708164 |
| 83 | striated muscle contraction (GO:0006941) | 2.52861207 |
| 84 | cerebellar granule cell differentiation (GO:0021707) | 2.52676748 |
| 85 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.51901597 |
| 86 | tachykinin receptor signaling pathway (GO:0007217) | 2.46925249 |
| 87 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.45852755 |
| 88 | myofibril assembly (GO:0030239) | 2.45595781 |
| 89 | termination of signal transduction (GO:0023021) | 2.45035169 |
| 90 | retinal metabolic process (GO:0042574) | 2.44878116 |
| 91 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.44497780 |
| 92 | purinergic receptor signaling pathway (GO:0035587) | 2.42939131 |
| 93 | beta-amyloid metabolic process (GO:0050435) | 2.42489761 |
| 94 | forebrain neuron development (GO:0021884) | 2.41917740 |
| 95 | fibroblast migration (GO:0010761) | 2.41411907 |
| 96 | tyrosine metabolic process (GO:0006570) | 2.40813967 |
| 97 | Golgi to plasma membrane protein transport (GO:0043001) | 2.40716504 |
| 98 | polyamine biosynthetic process (GO:0006596) | 2.40589392 |
| 99 | platelet activation (GO:0030168) | 2.39717320 |
| 100 | cardiac muscle hypertrophy (GO:0003300) | 2.39387738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.94889643 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15260932 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.73652649 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.50719405 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.42834907 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.40607844 |
| 7 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.37633872 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.36812628 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.31233307 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.25288898 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.05766348 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.04602083 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01106312 |
| 14 | GATA1_19941826_ChIP-Seq_K562_Human | 1.96305791 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.96112639 |
| 16 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.87620556 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.86907137 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80321489 |
| 19 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.77281026 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.76438979 |
| 21 | GATA2_19941826_ChIP-Seq_K562_Human | 1.71306988 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.70775619 |
| 23 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.64007740 |
| 24 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.64007740 |
| 25 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59735790 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53264758 |
| 27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.48311801 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40376682 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39702752 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38435917 |
| 31 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34670925 |
| 32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33763143 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30531429 |
| 34 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29153682 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23699182 |
| 36 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.23015505 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21715429 |
| 38 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.21186743 |
| 39 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.20185942 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19553630 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18962346 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17116167 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15437064 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15315704 |
| 45 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15282230 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.14964790 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14788739 |
| 48 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.14406160 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13388650 |
| 50 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13112407 |
| 51 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10688791 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10565856 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08140486 |
| 54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07981950 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06294326 |
| 56 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05396797 |
| 57 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.04897391 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04811940 |
| 59 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.01067088 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99103212 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98507766 |
| 62 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96120134 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95603954 |
| 64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95185813 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94848625 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94792934 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94574515 |
| 68 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.93554559 |
| 69 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93398513 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.93231915 |
| 71 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92345229 |
| 72 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.91474915 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91443342 |
| 74 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90844985 |
| 75 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90771112 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90366849 |
| 77 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.89371171 |
| 78 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89336160 |
| 79 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89227490 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88957580 |
| 81 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.88621948 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88029756 |
| 83 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.86158245 |
| 84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.85144937 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84682130 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84308502 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84253633 |
| 88 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.83557335 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83298039 |
| 90 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82504396 |
| 91 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80517632 |
| 92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.80509212 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80132284 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79610303 |
| 95 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.78971435 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.78262001 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77452367 |
| 98 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77065969 |
| 99 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76845482 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76637146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 4.91003400 |
| 2 | MP0004510_myositis | 4.08173121 |
| 3 | MP0005083_abnormal_biliary_tract | 3.77876656 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.47151839 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.28728567 |
| 6 | MP0008004_abnormal_stomach_pH | 3.05141539 |
| 7 | MP0004130_abnormal_muscle_cell | 2.92129835 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.77917030 |
| 9 | MP0000749_muscle_degeneration | 2.70712842 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.62315711 |
| 11 | MP0004270_analgesia | 2.58628411 |
| 12 | MP0000751_myopathy | 2.42938039 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.17852730 |
| 14 | MP0002736_abnormal_nociception_after | 2.11810925 |
| 15 | MP0003646_muscle_fatigue | 2.09558119 |
| 16 | MP0005171_absent_coat_pigmentation | 2.02523172 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 1.96598345 |
| 18 | MP0001502_abnormal_circadian_rhythm | 1.95328695 |
| 19 | MP0004215_abnormal_myocardial_fiber | 1.91576755 |
| 20 | MP0002735_abnormal_chemical_nociception | 1.89794720 |
| 21 | MP0000750_abnormal_muscle_regeneration | 1.82651352 |
| 22 | MP0002972_abnormal_cardiac_muscle | 1.68669513 |
| 23 | MP0002106_abnormal_muscle_physiology | 1.67104434 |
| 24 | MP0002822_catalepsy | 1.62323880 |
| 25 | MP0003828_pulmonary_edema | 1.60820087 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.58078080 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.56144278 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.55605723 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.55030103 |
| 30 | MP0004484_altered_response_of | 1.53996437 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.52585643 |
| 32 | MP0003879_abnormal_hair_cell | 1.52243282 |
| 33 | MP0008872_abnormal_physiological_respon | 1.45187124 |
| 34 | MP0005310_abnormal_salivary_gland | 1.42800363 |
| 35 | MP0003045_fibrosis | 1.40990007 |
| 36 | MP0003724_increased_susceptibility_to | 1.39972181 |
| 37 | MP0004233_abnormal_muscle_weight | 1.39425046 |
| 38 | MP0004859_abnormal_synaptic_plasticity | 1.37511371 |
| 39 | MP0005369_muscle_phenotype | 1.37434996 |
| 40 | MP0005187_abnormal_penis_morphology | 1.36471771 |
| 41 | MP0003638_abnormal_response/metabolism_ | 1.35893546 |
| 42 | MP0000230_abnormal_systemic_arterial | 1.35737004 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.35667710 |
| 44 | MP0000747_muscle_weakness | 1.34574613 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.32982604 |
| 46 | MP0005409_darkened_coat_color | 1.31151318 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 1.28698383 |
| 48 | MP0005451_abnormal_body_composition | 1.25431744 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.25431215 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.24953232 |
| 51 | MP0004085_abnormal_heartbeat | 1.23832792 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.23053689 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.21539826 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.20949584 |
| 55 | MP0006138_congestive_heart_failure | 1.18709996 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.18353249 |
| 57 | MP0001879_abnormal_lymphatic_vessel | 1.12751483 |
| 58 | MP0002734_abnormal_mechanical_nocicepti | 1.11773782 |
| 59 | MP0001486_abnormal_startle_reflex | 1.10938174 |
| 60 | MP0002009_preneoplasia | 1.04423108 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.01299600 |
| 62 | MP0005666_abnormal_adipose_tissue | 0.99621172 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.94284328 |
| 64 | MP0004134_abnormal_chest_morphology | 0.93323490 |
| 65 | MP0001661_extended_life_span | 0.92802403 |
| 66 | MP0003011_delayed_dark_adaptation | 0.90731569 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.89824257 |
| 68 | MP0000733_abnormal_muscle_development | 0.86984765 |
| 69 | MP0002006_tumorigenesis | 0.85048130 |
| 70 | MP0001765_abnormal_ion_homeostasis | 0.84573364 |
| 71 | MP0003635_abnormal_synaptic_transmissio | 0.84361139 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 0.83967156 |
| 73 | MP0002090_abnormal_vision | 0.83635227 |
| 74 | MP0002168_other_aberrant_phenotype | 0.83054756 |
| 75 | MP0004947_skin_inflammation | 0.82432192 |
| 76 | MP0004147_increased_porphyrin_level | 0.82283357 |
| 77 | MP0001544_abnormal_cardiovascular_syste | 0.82095210 |
| 78 | MP0005385_cardiovascular_system_phenoty | 0.82095210 |
| 79 | MP0000249_abnormal_blood_vessel | 0.81604630 |
| 80 | MP0001970_abnormal_pain_threshold | 0.79345011 |
| 81 | MP0003195_calcinosis | 0.78319776 |
| 82 | MP0003880_abnormal_central_pattern | 0.77340278 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.76707056 |
| 84 | MP0001851_eye_inflammation | 0.75921873 |
| 85 | MP0001905_abnormal_dopamine_level | 0.75704616 |
| 86 | MP0003303_peritoneal_inflammation | 0.71965192 |
| 87 | MP0010630_abnormal_cardiac_muscle | 0.70052073 |
| 88 | MP0000343_altered_response_to | 0.69698529 |
| 89 | MP0002272_abnormal_nervous_system | 0.67768827 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.66734583 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.66524744 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.66088768 |
| 93 | MP0008569_lethality_at_weaning | 0.66058150 |
| 94 | MP0005670_abnormal_white_adipose | 0.65342357 |
| 95 | MP0008874_decreased_physiological_sensi | 0.64063488 |
| 96 | MP0002572_abnormal_emotion/affect_behav | 0.63277200 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.62920025 |
| 98 | MP0004924_abnormal_behavior | 0.62920025 |
| 99 | MP0002108_abnormal_muscle_morphology | 0.62580880 |
| 100 | MP0003315_abnormal_perineum_morphology | 0.61970685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 7.07567866 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.94764527 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.87809775 |
| 4 | Prolonged bleeding time (HP:0003010) | 6.36681943 |
| 5 | Menorrhagia (HP:0000132) | 6.31429360 |
| 6 | Petechiae (HP:0000967) | 6.10539064 |
| 7 | Increased mean platelet volume (HP:0011877) | 5.88062826 |
| 8 | Abnormal platelet volume (HP:0011876) | 5.33508567 |
| 9 | Purpura (HP:0000979) | 4.55423346 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 4.46967332 |
| 11 | Exercise-induced myalgia (HP:0003738) | 4.45997156 |
| 12 | Epistaxis (HP:0000421) | 4.27272215 |
| 13 | Muscle fiber splitting (HP:0003555) | 4.16270172 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 3.98613829 |
| 15 | Dyschromatopsia (HP:0007641) | 3.97874463 |
| 16 | Gingival bleeding (HP:0000225) | 3.90833710 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.73355358 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 3.60972745 |
| 19 | Exercise-induced muscle cramps (HP:0003710) | 3.51606054 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 3.46585778 |
| 21 | Impaired platelet aggregation (HP:0003540) | 3.38362778 |
| 22 | Abnormal platelet function (HP:0011869) | 3.38362778 |
| 23 | Paralysis (HP:0003470) | 3.38318350 |
| 24 | Frequent falls (HP:0002359) | 3.27413573 |
| 25 | Poikilocytosis (HP:0004447) | 3.19579279 |
| 26 | Distal lower limb amyotrophy (HP:0008944) | 2.96550037 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 2.94351886 |
| 28 | Lower limb amyotrophy (HP:0007210) | 2.88643046 |
| 29 | Distal arthrogryposis (HP:0005684) | 2.86228822 |
| 30 | Rimmed vacuoles (HP:0003805) | 2.86178139 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.76522233 |
| 32 | Bundle branch block (HP:0011710) | 2.75684507 |
| 33 | Myopathic facies (HP:0002058) | 2.75594201 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.74179519 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 2.68727305 |
| 36 | Neck muscle weakness (HP:0000467) | 2.65766094 |
| 37 | Malignant hyperthermia (HP:0002047) | 2.61460092 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.59294516 |
| 39 | Abnormality of the calf musculature (HP:0001430) | 2.46936506 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.46837517 |
| 41 | Subaortic stenosis (HP:0001682) | 2.46837517 |
| 42 | Areflexia of lower limbs (HP:0002522) | 2.44442629 |
| 43 | Joint hemorrhage (HP:0005261) | 2.38451003 |
| 44 | Difficulty running (HP:0009046) | 2.37307433 |
| 45 | Dysmetric saccades (HP:0000641) | 2.35327502 |
| 46 | Ankle clonus (HP:0011448) | 2.35324157 |
| 47 | Arthropathy (HP:0003040) | 2.32501191 |
| 48 | Acanthocytosis (HP:0001927) | 2.32114369 |
| 49 | Upper limb muscle weakness (HP:0003484) | 2.31825559 |
| 50 | Focal motor seizures (HP:0011153) | 2.30765688 |
| 51 | Visual hallucinations (HP:0002367) | 2.25450321 |
| 52 | Sudden death (HP:0001699) | 2.24932890 |
| 53 | Febrile seizures (HP:0002373) | 2.22607757 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.15258079 |
| 55 | Progressive cerebellar ataxia (HP:0002073) | 2.11979196 |
| 56 | Fetal akinesia sequence (HP:0001989) | 2.11906187 |
| 57 | EMG: neuropathic changes (HP:0003445) | 2.11781691 |
| 58 | Bruising susceptibility (HP:0000978) | 2.11753332 |
| 59 | Gonadotropin excess (HP:0000837) | 2.10102141 |
| 60 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.09121273 |
| 61 | Dysdiadochokinesis (HP:0002075) | 2.08420108 |
| 62 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07802128 |
| 63 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06584222 |
| 64 | Generalized muscle weakness (HP:0003324) | 2.01092718 |
| 65 | Decreased central vision (HP:0007663) | 2.00470010 |
| 66 | Bulbar palsy (HP:0001283) | 1.98559784 |
| 67 | Back pain (HP:0003418) | 1.95114659 |
| 68 | Diplopia (HP:0000651) | 1.95024342 |
| 69 | Abnormality of binocular vision (HP:0011514) | 1.95024342 |
| 70 | Round ear (HP:0100830) | 1.93872855 |
| 71 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92145365 |
| 72 | Facial diplegia (HP:0001349) | 1.91525570 |
| 73 | Abnormal auditory evoked potentials (HP:0006958) | 1.90304196 |
| 74 | Genetic anticipation (HP:0003743) | 1.90024999 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90009133 |
| 76 | Muscular dystrophy (HP:0003560) | 1.88337177 |
| 77 | Ulnar deviation of the wrist (HP:0003049) | 1.87492166 |
| 78 | Myotonia (HP:0002486) | 1.86250670 |
| 79 | Abnormality of the prostate (HP:0008775) | 1.85120217 |
| 80 | Nonprogressive disorder (HP:0003680) | 1.83754507 |
| 81 | Abnormal finger flexion creases (HP:0006143) | 1.83551498 |
| 82 | Abnormality of lateral ventricle (HP:0030047) | 1.81741749 |
| 83 | Heart block (HP:0012722) | 1.80741459 |
| 84 | Lower limb muscle weakness (HP:0007340) | 1.80522992 |
| 85 | Choroideremia (HP:0001139) | 1.80000122 |
| 86 | Vascular calcification (HP:0004934) | 1.77596590 |
| 87 | Generalized aminoaciduria (HP:0002909) | 1.75752686 |
| 88 | Lip pit (HP:0100267) | 1.75441799 |
| 89 | Hypoplastic iliac wings (HP:0002866) | 1.71976512 |
| 90 | Rapidly progressive (HP:0003678) | 1.71548760 |
| 91 | Calcaneovalgus deformity (HP:0001848) | 1.71478499 |
| 92 | Spastic gait (HP:0002064) | 1.71032707 |
| 93 | Spinal rigidity (HP:0003306) | 1.70074864 |
| 94 | Weak cry (HP:0001612) | 1.69964759 |
| 95 | Rhabdomyolysis (HP:0003201) | 1.66890578 |
| 96 | Abnormal atrioventricular conduction (HP:0005150) | 1.66458811 |
| 97 | Gaze-evoked nystagmus (HP:0000640) | 1.66182030 |
| 98 | Absent phalangeal crease (HP:0006109) | 1.65474708 |
| 99 | Fatigable weakness (HP:0003473) | 1.64831861 |
| 100 | Abnormality of the neuromuscular junction (HP:0003398) | 1.64831861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.17968396 |
| 2 | MST4 | 3.78782298 |
| 3 | BRSK2 | 3.29292234 |
| 4 | PHKG2 | 2.82039166 |
| 5 | PHKG1 | 2.82039166 |
| 6 | RIPK4 | 2.79220040 |
| 7 | GRK7 | 2.77617542 |
| 8 | TRIM28 | 2.46431561 |
| 9 | EPHA2 | 2.40089696 |
| 10 | SIK3 | 2.36747708 |
| 11 | PIK3CG | 2.27878606 |
| 12 | BMX | 1.92796550 |
| 13 | GRK5 | 1.91950802 |
| 14 | CAMK1G | 1.83732493 |
| 15 | PTK2B | 1.81280575 |
| 16 | SIK1 | 1.65948131 |
| 17 | MYLK | 1.64622698 |
| 18 | TTN | 1.61561978 |
| 19 | AKT3 | 1.51716440 |
| 20 | STK24 | 1.47693961 |
| 21 | BTK | 1.38594452 |
| 22 | BRSK1 | 1.36897416 |
| 23 | TLK1 | 1.32659924 |
| 24 | PAK3 | 1.30804873 |
| 25 | SGK2 | 1.27854427 |
| 26 | MAP3K3 | 1.22884212 |
| 27 | CAMK1D | 1.20560969 |
| 28 | GRK1 | 1.20035759 |
| 29 | MARK1 | 1.18771922 |
| 30 | MAPK12 | 1.12361936 |
| 31 | LATS2 | 1.12279101 |
| 32 | SYK | 1.11823564 |
| 33 | TEC | 1.07992003 |
| 34 | MAP2K3 | 1.07353789 |
| 35 | PNCK | 1.05061243 |
| 36 | DAPK2 | 1.02161494 |
| 37 | MAP3K7 | 0.97309775 |
| 38 | TAOK3 | 0.92340896 |
| 39 | ADRBK1 | 0.89237051 |
| 40 | MINK1 | 0.89012163 |
| 41 | TAOK2 | 0.85213157 |
| 42 | MAPKAPK3 | 0.84471132 |
| 43 | CSF1R | 0.82440106 |
| 44 | SGK3 | 0.81966792 |
| 45 | NTRK1 | 0.80504280 |
| 46 | LMTK2 | 0.79463059 |
| 47 | PLK2 | 0.79457551 |
| 48 | PRKD1 | 0.79307978 |
| 49 | MAPK13 | 0.78179726 |
| 50 | IKBKB | 0.77427168 |
| 51 | PRKAA1 | 0.75105489 |
| 52 | HCK | 0.74122011 |
| 53 | PKN1 | 0.70229575 |
| 54 | SGK494 | 0.70185200 |
| 55 | SGK223 | 0.70185200 |
| 56 | RIPK1 | 0.69590327 |
| 57 | WEE1 | 0.69464957 |
| 58 | TNK2 | 0.68357538 |
| 59 | STK38 | 0.67799039 |
| 60 | CCNB1 | 0.67327664 |
| 61 | MUSK | 0.63448310 |
| 62 | CAMKK2 | 0.63408712 |
| 63 | CAMK2G | 0.60296014 |
| 64 | PDK1 | 0.60216782 |
| 65 | BCR | 0.59992553 |
| 66 | PDPK1 | 0.58388228 |
| 67 | CSNK1A1L | 0.58162947 |
| 68 | BLK | 0.55380706 |
| 69 | PRKAA2 | 0.54616834 |
| 70 | MAP3K9 | 0.54233604 |
| 71 | CAMK1 | 0.52245911 |
| 72 | MAP2K1 | 0.51683273 |
| 73 | MARK2 | 0.51552853 |
| 74 | PAK1 | 0.51473273 |
| 75 | DMPK | 0.51007405 |
| 76 | STK38L | 0.49462110 |
| 77 | PRKACG | 0.48724268 |
| 78 | MAPK7 | 0.48237519 |
| 79 | CAMK2B | 0.47992445 |
| 80 | CAMK2D | 0.47214623 |
| 81 | BMPR2 | 0.45562997 |
| 82 | DAPK3 | 0.45538059 |
| 83 | PIK3CA | 0.45520954 |
| 84 | ROCK1 | 0.44810656 |
| 85 | ERBB2 | 0.41539036 |
| 86 | MAP3K5 | 0.40471961 |
| 87 | PRKG1 | 0.40291364 |
| 88 | CSNK1D | 0.40174745 |
| 89 | ILK | 0.37578786 |
| 90 | GRK6 | 0.36738745 |
| 91 | FER | 0.35847449 |
| 92 | CAMK4 | 0.35839078 |
| 93 | ZAP70 | 0.34466397 |
| 94 | CSNK1G3 | 0.33741880 |
| 95 | CAMK2A | 0.33642424 |
| 96 | WNK1 | 0.32926357 |
| 97 | PINK1 | 0.32784253 |
| 98 | PRKACA | 0.32640368 |
| 99 | STK3 | 0.32432223 |
| 100 | PRKD3 | 0.32251346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 2.81368671 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 2.26714882 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.78668612 |
| 4 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.78478360 |
| 5 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.67727378 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.67435862 |
| 7 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.61078627 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.59259394 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.57965179 |
| 10 | Alcoholism_Homo sapiens_hsa05034 | 1.55973149 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.54256104 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42676747 |
| 13 | Gap junction_Homo sapiens_hsa04540 | 1.41833633 |
| 14 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41187171 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.37138850 |
| 16 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.35395627 |
| 17 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.33296844 |
| 18 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32782660 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30710820 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.29885680 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.28389607 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28075078 |
| 23 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.25290033 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24602240 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.24224566 |
| 26 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.23036570 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.22006153 |
| 28 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21111346 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.19316762 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.17108572 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16095195 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15662586 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14129999 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.14102276 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13543803 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.13393504 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.12611185 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11581712 |
| 39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.11254983 |
| 40 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10039195 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.07585920 |
| 42 | Endocytosis_Homo sapiens_hsa04144 | 1.07287489 |
| 43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05702304 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04252643 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01064656 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00311794 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99105848 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.98963452 |
| 49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.97591722 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96235389 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95880817 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94573499 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92639151 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91173419 |
| 55 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91156197 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89984745 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87753396 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 0.85921627 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.85157189 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83858929 |
| 61 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83222413 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81502895 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81426170 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80973391 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.80447927 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.79786750 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.79274392 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77513148 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77102797 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76355093 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75259567 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72283445 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71632442 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69798633 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68856827 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.64412553 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64237665 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63557816 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63284609 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62241716 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62131612 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61038016 |
| 83 | Tight junction_Homo sapiens_hsa04530 | 0.60995071 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60864613 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58396357 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58276151 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.57696393 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56195897 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54684182 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54397426 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54225314 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.54173485 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53655514 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53276220 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.51995290 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50138580 |
| 97 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49309042 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48939277 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48697569 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.46062085 |

